Open AccessRitonavir and saquinavir combination therapy for the treatment of HIV infection
Author(s) -
D. William Cameron,
Anthony Japour,
Yi Xu,
Ann Hsu,
John W. Mellors,
Charles Farthing,
Calvin Cohen,
Donald M. Poretz,
Martin Markowitz,
Stephen Follansbee,
Jonathan B. Angel,
Deborah McMahon,
David D. Ho,
V. Devanarayan,
Richard A. Rode,
Miklos Salgo,
Dale J. Kempf,
R. Granneman,
John M. Leonard,
Eugene Sun
Publication year - 1999
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-199902040-00009
Subject(s) - saquinavir , ritonavir , medicine , regimen , discontinuation , protease inhibitor (pharmacology) , randomized controlled trial , viral load , reverse transcriptase inhibitor , adverse effect , immunology , human immunodeficiency virus (hiv) , antiretroviral therapy
To evaluate the safety and antiretroviral activity of ritonavir (Norvir) and saquinavir (Invirase) combination therapy in patients with HIV infection.